hyperprolactinemia: An acquired metabolic disease that has_material_basis_in the presence of abnormally-high levels of prolactin in the blood.
Filter registries Inpat., Oupat., Death
Check pre-conditions None
Include endpoints None
Check conditions None
Apply sex-specific rule None
E4_HYPERPRO
Extra metadata
List of similar endpoints to
Hyperprolactinaemia
based on the number of shared cases.
Broader endpoints:
Narrower endpoints:
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 683 | 570 | 113 |
| Unadjusted prevalence (%) | 0.26 | 0.39 | 0.10 |
| Mean age at first event (years) | 38.19 | 35.81 | 50.18 |
| Follow-up | Absolute risk | HR [95% CI] | p | N |
|---|---|---|---|---|
| 1998–2019 | 0.10 | 7.43 [3.63, 15.21] | 4.1e-8 | 17 |
| 15 years | 0.04 | 5.48 [2.32, 12.97] | 1.1e-4 | 10 |
| 5 years | - | - | - | - |
| 1 year | - | - | - | - |
Index endpoint: E4_HYPERPRO – Hyperprolactinaemia
GWS hits: 0
before Hyperprolactinaemia
after Hyperprolactinaemia
Loading survival analyses plot
Loading survival analyses table